Park Ha Biological Technology Co., Ltd. (PHH)

NASDAQ: PHH · Real-Time Price · USD
9.53
-1.29 (-11.92%)
Mar 25, 2025, 4:00 PM EST - Market closed
-11.92%
Market Cap 251.35M
Revenue (ttm) 2.38M
Net Income (ttm) 478,561
Shares Out 26.37M
EPS (ttm) 0.02
PE Ratio 525.22
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 637,600
Open 10.71
Previous Close 10.82
Day's Range 9.45 - 11.88
52-Week Range 3.70 - 13.98
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About PHH

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People’s Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People’s R... [Read more]

IPO Date Dec 27, 2024
Employees 17
Stock Exchange NASDAQ
Ticker Symbol PHH
Full Company Profile

Financial Performance

In 2024, PHH's revenue was $2.38 million, a decrease of -3.14% compared to the previous year's $2.46 million. Earnings were $478,561, a decrease of -43.83%.

Financial numbers in USD Financial Statements

News

Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering

Wuxi, China, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) (the “Company”), a company focused on developing private skincare labels, direct skincare product s...

3 months ago - GlobeNewsWire

Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering

Wuxi, China, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (the "Company"), a company focused on developing private skincare labels, direct skincare product sales, and fran...

3 months ago - GlobeNewsWire

Park Ha Biological Aims For U.S. IPO At Sky-High Valuation

Park Ha Biological Technology Co., Ltd. seeks $6 million in an IPO, but has wildly excessive valuation expectations given its small size and fluctuating financial metrics. The company faces numerous r...

5 months ago - Seeking Alpha

U.S. IPO Weekly Recap: Small Issuers Close Out August IPO Market

While major IPOs are on hold until after Labor Day, three small deals were completed in the last week of August. Two SPACs, GigCapital7 and Black Spade Acquisition II, raised $200 million and $150 mil...

Other symbols: AZIJBDISPAITDTH
7 months ago - Seeking Alpha

Chinese skincare product company Park Ha Biological Technology files and sets terms for a $7 million US IPO

Park Ha Biological Technology, which sells skincare and cosmetic products in China, filed on Monday with the SEC to raise up to $7 million in an initial public offering.

7 months ago - Renaissance Capital

Park Ha Biological Technology IPO Registration Document (F-1)

Park Ha Biological Technology has filed to go public with an IPO on the NASDAQ.

7 months ago - SEC